Recognizing a lack of diversity in their clinical trials and research, St. Louis-based Ascension set out to improve in this area, and has made strides that have recently received recognition. This “mission-aligned” work has been a focus for Fredrick Masoudi, MD, chief science officer at the health system, who began his role in 2021.
Read the full post on Becker's Hospital Review - Healthcare News
